These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27943236)
1. The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide. Jennings L; Nestor L; Molloy O; Hughes R; Moriarty B; Kirby B Br J Dermatol; 2017 Sep; 177(3):858-859. PubMed ID: 27943236 [TBL] [Abstract][Full Text] [Related]
2. Liraglutide for the treatment of obesity among patients with hidradenitis suppurativa. Nicolau J; Nadal A; Sanchís P; Pujol A; Masmiquel L; Nadal C Med Clin (Barc); 2024 Feb; 162(3):118-122. PubMed ID: 38044187 [TBL] [Abstract][Full Text] [Related]
3. Metformin use in hidradenitis suppurativa. Jennings L; Hambly R; Hughes R; Moriarty B; Kirby B J Dermatolog Treat; 2020 May; 31(3):261-263. PubMed ID: 30893570 [No Abstract] [Full Text] [Related]
4. Ethics of diabetic drugs for weight loss in hidradenitis suppurativa patients. Katsetos M; Torre K; Grant-Kels JM J Am Acad Dermatol; 2024 Aug; 91(2):406-407. PubMed ID: 37558092 [No Abstract] [Full Text] [Related]
5. Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases. Vilarrasa E; Nicolau J; de la Cueva P; Goday A; Gallardo F; Martorell A; Carrascosa JM Actas Dermosifiliogr; 2024 Jan; 115(1):56-65. PubMed ID: 37451337 [TBL] [Abstract][Full Text] [Related]
6. Current and emerging nonsurgical treatment options for hidradenitis suppurativa. Kerdel FA Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460 [TBL] [Abstract][Full Text] [Related]
11. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab. Harde V; Mrowietz U J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236 [TBL] [Abstract][Full Text] [Related]
12. Hidradenitis suppurativa in the pediatric population. Liy-Wong C; Pope E; Lara-Corrales I J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613 [TBL] [Abstract][Full Text] [Related]
13. One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast. Lanna C; Mazzilli S; Zangrilli A; Bianchi L; Campione E Dermatol Ther; 2019 Nov; 32(6):e13089. PubMed ID: 31577864 [TBL] [Abstract][Full Text] [Related]
14. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429 [TBL] [Abstract][Full Text] [Related]
15. Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence. van der Zee HH; Gulliver WP Dermatol Clin; 2016 Jan; 34(1):91-6. PubMed ID: 26617362 [TBL] [Abstract][Full Text] [Related]
16. Liraglutide for weight loss in obese people. Thum T; Anker SD Lancet; 2010 Feb; 375(9714):551-2; author reply 552-3. PubMed ID: 20159285 [No Abstract] [Full Text] [Related]
18. GLP-1 analogue-induced weight loss does not improve obesity-induced AT dysfunction. Pastel E; McCulloch LJ; Ward R; Joshi S; Gooding KM; Shore AC; Kos K Clin Sci (Lond); 2017 Mar; 131(5):343-353. PubMed ID: 28049736 [TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients. Scheinfeld N Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361 [TBL] [Abstract][Full Text] [Related]
20. Liraglutide for Type 2 diabetes and obesity: a 2015 update. Iepsen EW; Torekov SS; Holst JJ Expert Rev Cardiovasc Ther; 2015; 13(7):753-67. PubMed ID: 26106933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]